• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBionexus Gene Lab
    Picture of Bionexus Gene Lab logo

    BGLC — Bionexus Gene Lab Share News

    $1.190.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $3.49m
    • Enterprise Value
      $2.31m
    • Revenue
      $7.42m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BGLC Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BGLC Dividends
    • Brief: Kim Hai Wong & Majority Of Shareholders Executed Written Consent Without Meeting Of Shareholders Of BioNexus Gene Lab Corp

      17/01/2024 11:18
    • U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker

      24/11/2023 14:25
    • Brief: Bionexus Gene Lab Says On Oct 12, Board Approved Appointment Of Chi Yuen Leong As CEO

      16/10/2023 16:03
    • Brief: Bionexus Gene Lab Corp Says On Oct 4, Sook Keng Yeoh, CEO & Member Of Board, Tendered His Resignation Letter To Co From His Positions At Co

      11/10/2023 16:49
    • Brief: Bionexus Gene Lab Corp. Announces Pricing Of $5 Mln Public Offering And Uplisting To Nasdaq

      20/07/2023 19:07
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.